About Titan Medical (TSE:TMD)
Titan Medical Inc. is a Canada-based company engaged in developing robotic surgical system for use in connection with minimally invasive surgery (MIS) (surgery without large incisions). The Company is developing the SPORT (Single Port Orifice Robotic Technology) Surgical System, a single-port/single-incision robotic surgical system to provide tele-operation (remote surgery) capabilities. The SPORT Surgical System comprises a surgeon-controlled robotic platform (patient cart) that includes a three dimensional (3D) high definition vision system and multi-articulating instruments for performing MIS procedures, and a surgeon workstation that provides the surgeon with an ergonomic interface to the robotic platform and also provides a 3D endoscopic view of inside a patient's body during MIS procedures. The SPORT Surgical System is also being developed to allow for data collection and analytics that could be utilized by the surgeon and/or operation room teams.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Medical Appliances & Equipment
- Sub-Industry: N/A
- Symbol: TSE:TMD
- CUSIP: N/A
- Web: www.titanmedicalinc.com
- Market Cap: C$109.05 million
- Outstanding Shares: 247,851,000
- 50 Day Moving Avg: C$0.25
- 200 Day Moving Avg: C$0.26
- 52 Week Range: C$0.13 - C$0.72
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- EBITDA: ($15,830,000.00)
- Return on Equity: -2,815.92%
- Return on Assets: -80.62%
- Average Volume: 1.35 million shs.
- Short Ratio: 0.66
Frequently Asked Questions for Titan Medical (TSE:TMD)
What is Titan Medical's stock symbol?
Titan Medical trades on the Toronto Stock Exchange (TSX) under the ticker symbol "TMD."
When will Titan Medical make its next earnings announcement?
Who are some of Titan Medical's key competitors?
Some companies that are related to Titan Medical include Corindus Vascular Robotics (CVRS), OncoCyte Corp (OCX), Allergy Therapeutics plc (AGY), Chromadex Corp (CDXC), Kadmon Holdings (KDMN), Organovo Holdings (ONVO), Silence Therapeutics plc (SLN), Synthetic Biologics (SYN), Palatin Technologies (PTN), Sinclair Pharma PLC (SPH), Asterias Biotherapeutics (AST), Asterias Biotherapeutics (AST), Verona Pharma Plc (VRP), ImmuPharma PLC (IMM), MaxCyte (MXCT), Bovie Medical (BVX), Arch Therapeutics (ARTH) and Ekf Diagnostics Holding PLC (EKF).
Who are Titan Medical's key executives?
Titan Medical's management team includes the folowing people:
- Martin C. Bernholtz, Chairman of the Board
- David J. McNally, President, Chief Executive Officer, Director
- Stephen D. Randall, Chief Financial Officer, Secretary
- Perry A. Genova Ph.D., Vice President - Research & Development
- John E. Barker, Director
- Bruce Gilles Wolff M.D., Independent Director
How do I buy Titan Medical stock?
Shares of Titan Medical and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Titan Medical's stock price today?
MarketBeat Community Rating for Titan Medical (TSE TMD)MarketBeat's community ratings are surveys of what our community members think about Titan Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Titan Medical stock can currently be purchased for approximately C$0.44.
Consensus Ratings for Titan Medical (TSE:TMD) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Buy Rating|
|Consensus Rating:||Buy (Score: 3.00)|
|Consensus Price Target: ||N/A|Consensus Price Target History for Titan Medical (TSE:TMD)
Analysts' Ratings History for Titan Medical (TSE:TMD)
(Data available from 10/22/2015 forward)
|2/14/2017||Roth Capital||Reiterated Rating||Buy|
Earnings History for Titan Medical (TSE:TMD)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Titan Medical (TSE:TMD)
2017 EPS Consensus Estimate: ($0.30)
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Titan Medical (TSE:TMD)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Titan Medical (TSE:TMD)Insider Trades by Quarter for Titan Medical (TSE:TMD)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
Headline Trends for Titan Medical (TSE:TMD)
Latest Headlines for Titan Medical (TSE:TMD)
Loading headlines, please wait.
Titan Medical (TMD) Chart for Sunday, October, 22, 2017